DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 10 2024
0mins
Source: Business Insider
- Deciphera Pharmaceuticals Q1 2024 Earnings: Reported earnings per share of -52 cents, beating analyst estimates of -55 cents.
- Deciphera Pharmaceuticals Revenue: Generated revenue of $45.00 million, slightly below the analyst estimate of $46.28 million.
- InvestorPlace Earnings Project: Utilizes TradeSmith data to automate coverage of quarterly earnings reports for companies like Deciphera Pharmaceuticals.
- Quick Reporting: Articles are published without human intervention to inform readers promptly about the latest financial figures.
- Additional Information: The post also includes investment advice and highlights on other companies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
